These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35273691)

  • 1. Klotho/FGF23 and Wnt in SHPT associated with CKD
    Wu Q; Fan W; Zhong X; Zhang L; Niu J; Gu Y
    Am J Transl Res; 2022; 14(2):876-887. PubMed ID: 35273691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Klotho/FGF23 axis mediates high phosphate-induced vascular calcification in vascular smooth muscle cells via Wnt7b/β-catenin pathway.
    Chen YX; Huang C; Duan ZB; Xu CY; Chen Y
    Kaohsiung J Med Sci; 2019 Jul; 35(7):393-400. PubMed ID: 31001900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease.
    Carrillo-López N; Panizo S; Alonso-Montes C; Román-García P; Rodríguez I; Martínez-Salgado C; Dusso AS; Naves M; Cannata-Andía JB
    Kidney Int; 2016 Jul; 90(1):77-89. PubMed ID: 27165819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of FGF-23-mediated ERK/MAPK signaling pathway on parathyroid hormone secretion of parathyroid cells in rats with secondary hyperparathyroidism.
    Chen XJ; Chen X; Wu WJ; Zhou Q; Gong XH; Shi BM
    J Cell Physiol; 2018 Sep; 233(9):7092-7102. PubMed ID: 29633272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of HOTAIR attenuates Pi-induced vascular calcification by inhibiting Wnt/β-catenin through regulating miR-126/Klotho/SIRT1 axis.
    Chen Y; Huang C; Zhu SY; Zou HC; Xu CY; Chen YX
    Mol Cell Biochem; 2021 Oct; 476(10):3551-3561. PubMed ID: 34014438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The suppressive effect of soluble Klotho on fibroblastic growth factor 23 synthesis in UMR-106 osteoblast-like cells.
    Ma L; Gao M; Wu L; Zhao X; Mao H; Xing C
    Cell Biol Int; 2018 Sep; 42(9):1270-1274. PubMed ID: 29851201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-129 Blocks Secondary Hyperparathyroidism-Inducing Fgf23/αKlotho Signaling in Mice with Chronic Kidney Disease.
    Xu M; Li H; Bai Y; He J; Chen R; An N; Li Y; Dong Y
    Am J Med Sci; 2021 May; 361(5):624-634. PubMed ID: 33781552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA-SNHG29 inhibits vascular smooth muscle cell calcification by downregulating miR-200b-3p to activate the α-Klotho/FGFR1/FGF23 axis.
    Huang C; Zhan JF; Chen YX; Xu CY; Chen Y
    Cytokine; 2020 Dec; 136():155243. PubMed ID: 32818704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of the Fibroblast Growth Factor 23/α-Klotho Axis in Peripheral Blood Mononuclear Cell Inflammation in Alzheimer's Disease.
    Li B; Zhou M; Peng J; Yang Q; Chu J; Li R; Jiang Y
    Immunol Invest; 2022 Jul; 51(5):1471-1484. PubMed ID: 34503373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the RANK/RANKL/OPG and Wnt/β-Catenin Systems in CKD Bone and Cardiovascular Disorders.
    Carrillo-López N; Martínez-Arias L; Fernández-Villabrille S; Ruiz-Torres MP; Dusso A; Cannata-Andía JB; Naves-Díaz M; Panizo S;
    Calcif Tissue Int; 2021 Apr; 108(4):439-451. PubMed ID: 33586001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RPS15A Mediates PI3K/AKT Signaling-Induced Parathyroid Cell Proliferation in Rats with Secondary Hyperparathyroidism.
    Chen R; He J; Wang C; Xu M; An N; Bai Y
    Ann Clin Lab Sci; 2023 Mar; 53(2):313-321. PubMed ID: 37094854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis.
    Koizumi M; Komaba H; Fukagawa M
    Contrib Nephrol; 2013; 180():110-23. PubMed ID: 23652554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of secondary hyperparathyroidism serum on endothelial cells and intervention with Klotho.
    Chen C; Mao H; Yu X; Sun B; Zeng M; Zhao X; Qian J; Liu J; Xing C
    Mol Med Rep; 2015 Aug; 12(2):1983-90. PubMed ID: 25873020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients.
    Krajisnik T; Olauson H; Mirza MA; Hellman P; Akerström G; Westin G; Larsson TE; Björklund P
    Kidney Int; 2010 Nov; 78(10):1024-32. PubMed ID: 20686451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects of miR-29a on diabetic glomerular dysfunction by modulation of DKK1/Wnt/β-catenin signaling.
    Hsu YC; Chang PJ; Ho C; Huang YT; Shih YH; Wang CJ; Lin CL
    Sci Rep; 2016 Jul; 6():30575. PubMed ID: 27460630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Klotho, FGF23, and FGF receptors in chronic kidney disease: a yin-yang situation?
    Drüeke TB
    Kidney Int; 2010 Dec; 78(11):1057-60. PubMed ID: 21076444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlations of FGF23 and Klotho with cardiovascular injury in chronic kidney disease patients].
    Gan L; Zhou Q
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Sep; 42(9):1058-1065. PubMed ID: 28989152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fucoidan Ameliorates Renal Injury-Related Calcium-Phosphorus Metabolic Disorder and Bone Abnormality in the CKD-MBD Model Rats by Targeting FGF23-Klotho Signaling Axis.
    Liu BH; Chong FL; Yuan CC; Liu YL; Yang HM; Wang WW; Fang QJ; Wu W; Wang MZ; Tu Y; Wan ZY; Wan YG; Wu GW
    Front Pharmacol; 2020; 11():586725. PubMed ID: 33708111
    [No Abstract]   [Full Text] [Related]  

  • 19. Dual-specificity phosphatases are implicated in severe hyperplasia and lack of response to FGF23 of uremic parathyroid glands from rats.
    Román-García P; Carrillo-López N; Naves-Díaz M; Rodríguez I; Ortiz A; Cannata-Andía JB
    Endocrinology; 2012 Apr; 153(4):1627-37. PubMed ID: 22334717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients.
    Komaba H; Goto S; Fujii H; Hamada Y; Kobayashi A; Shibuya K; Tominaga Y; Otsuki N; Nibu K; Nakagawa K; Tsugawa N; Okano T; Kitazawa R; Fukagawa M; Kita T
    Kidney Int; 2010 Feb; 77(3):232-8. PubMed ID: 19890272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.